ARCHIVES

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

This article is from The Cancer Letter archive.

Vol. 06 No. 29 | July 18, 1980

Download PDF Visit The Full Archive

Related Articles

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002